Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New training and device could help amputees use bionic arms more easily

NCT ID NCT06853938

Disease control Sponsor: University of Alberta Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a new muscle training program and a muscle-controlled prosthetic arm for people who have lost an arm above the elbow. Participants will first receive a bone-anchored implant and nerve surgery to improve muscle signals. Then they will use a myoelectric prosthesis and be followed for up to a year to see if it helps them use the arm more in daily life. Only 5 people will take part, so the results are very early.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
myoelectric prosthesis and muscle training protocol
What this could lead to
If successful, this could lead to better control and daily use of advanced prosthetic arms for people with above-elbow amputations, improving their quality of life.
What could go wrong
This is a very small early study with only 5 participants, so results may not apply to everyone. The training and device may not work well for all users.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 5 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2025

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Individuals with transhumeral amputation who: 1. are between 18 and 65 years old, 2. have been scheduled to undergo osseointegration by the Alberta Limb Osseointegration Program. 3. demonstrate adequate pain-free shoulder range of motion to perform the required tasks and have potential muscle signals for myoelectric control to be able to undertake the muscle signal training 4. willing to undergo all of the study procedures and follow-up. Exclusion Criteria: Individuals who: 1. are unable to comply with treatment or follow-up processes, 2. are unable to understand English sufficiently to provide full informed consent. 3. have shoulder pathology on the side of the amputation (arthritis, adhesive capsulitis, chronic rotator cuff, or musculoskeletal dysfunction) that would negatively affect the ability to perform the training and functional assessments, 4. have insufficient muscle signals to operate a myoelectric prosthesis

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Transhumeral amputation are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

terminal transverse defects of arm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Transhumeral amputation

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Glenrose Rehabilitation Hospital

    RECRUITING

    Edmonton, Alberta, T5G 0B7, Canada

  • University of Alberta

    RECRUITING

    Edmonton, Alberta, T6G2R3, Canada